Malika Ammam received her MS degree from the University of Pierre et Marie CURIE in July 2002 and her PhD from the University of Paris Sud XI, France in September 2005. From 2006 to 2007, she worked as a research fellow at the University of Kansas in collaboration with Pinnacle Technology Inc. (USA). From 2007 to 2010, she was a research associate at KU Leuven, Belgium. From 2010 to 2012, she worked at the University of Ontario Institute of Technology in collaboration with Alcohol Countermeasure Systems Corporation, Canada. She has also held the prestigious Rosalind Franklin fellowship.
A new imaging agent has been found to be safe, fast, and efficient in visualizing metastatic prostate cancer, even in regions where the visualization is often challenging, such as bone and ... Read more
A recent study led by scientists at Toronto’s Princess Margaret Cancer Centre, University Health Network, have identified 45 genes linked to the development and progression of prostate cancer. The study, ... Read more
UK researchers proved that a hypofractionated high-dose intensity-modulated radiotherapy compared to conventional radiotherapy for prostate cancer, significantly impacts patient treatment time and outcome, and will save tens of millions in cost for the the National Health ... Read more
Rising incidences of cancer across Europe, largely the result of people living longer, will increase demand for radiotherapy as a treatment option by an average of 16 percent by 2025 — with the ... Read more